Kronos Bio, Inc.

About Kronos Bio, Inc.

Kronos Bio is a biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting deregulated transcription factors involved in cancer and autoimmune diseases. Using proprietary systems biology and drug discovery platforms, it aims to modulate critical nodes within transcriptional regulatory networks. Its core approach involves precision medicine strategies to develop targeted treatments for high unmet medical needs in oncology and autoimmune disorders.